Premium
Rituximab in three children with relapsed/refractory B‐cell acute lymphoblastic leukaemia/Burkitt non‐Hodgkin's lymphoma
Author(s) -
De Vries Maaike J.,
Veerman Anjo J. P.,
Zwaan Christian M.
Publication year - 2004
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2004.04925.x
Subject(s) - medicine , rituximab , lymphoma , cd20 , b cell , gastroenterology , pathology , immunology , antibody
M., Brown, E.J., Peters, L.L., Van Kim, C.L., Cartron J.P. & Colin, Y. (2003) Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood, 101, 338–344. Nance, S.J., Arndt, P. & Garratty, G. (1987) Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion, 27, 449–452. Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C.F., Gresham, H.D. & Lindberg, F.P. (2000) Role of CD47 as a marker of self on red blood cells. Science, 288, 2051–2054.